Rolled white towels, a eucalyptus sprig, a bowl of water and three pale stones on a marble counter
BODY CONTOURING

Body Contouring in Dallas

Fat, muscle, loose skin, cellulite and contouring after GLP-1 weight loss: the FDA clearance behind each option and the published numbers that go with it.

Avg. Cost
This site does not publish a Dallas price range for body contouring
Downtime
Cryolipolysis has none. In the Avéli study, 73.5% of patients were back to normal activities by the end of the first week
Results Last
After cryolipolysis, the body clears treated fat cells over 4 to 6 months. Avéli data run out to 1 year
Appointment
Depends on the device; published non-invasive fat treatments range from about 25 minutes to about an hour

Overview

Five different problems under one name

People use “body contouring” for treatments that address stubborn fat, weak muscle tone, loose skin, cellulite, and surplus skin after weight loss. Those are five separate problems. No one treatment fixes all of them, and the FDA has cleared or approved each product for named uses only:

  • Fat: CoolSculpting (FDA clearance K233732) and SculpSure (FDA clearance K182741) are cleared to break down fat in listed body areas.
  • Abdominal fat and circumference: Emsculpt Neo carries clearance for both (FDA clearance K192224).
  • Skin: Morpheus8 is cleared for procedures that need soft tissue coagulated or contracted (FDA clearance K231790).
  • Cellulite: Avéli is cleared for the look of cellulite on adult women’s buttocks and thighs (FDA clearance K221336).
  • Surplus skin: that is a job for surgery. ASPS describes a tummy tuck as removing excess skin and fat and, usually, repairing abdominal muscles that have separated or weakened (ASPS on tummy tuck).

The useful first sentence at a consultation is the one that names which of those five you care about. It changes the shortlist. Loose skin is a good example: ASPS says it, or poor tone, can make cryolipolysis a weak choice (ASPS on cryolipolysis).

Three recent developments are worth knowing before you book anywhere in the Dallas area:

  1. GLP-1 weight loss includes muscle. In a SURMOUNT-1 substudy, about 25% of the weight lost on tirzepatide was lean mass, the same proportion as on placebo (Look et al., 2025).
  2. Newer PAH estimates are higher. Recently published rates of paradoxical adipose hyperplasia after cryolipolysis sit above the first estimate (Mah et al., 2025).
  3. The FDA has issued safety communications about Renuvion/J-Plasma (FDA on Renuvion/J-Plasma) and about RF microneedling (FDA on RF microneedling).
Quick factsWhat the sources say
Dallas costThis site lists no Dallas price range for body contouring
Time in the chairCryolipolysis takes about an hour (ASPS on cryolipolysis). One study of a 1060 nm laser used a single 25-minute session (Kislevitz et al., 2021)
DowntimeFor cryolipolysis, ASPS lists no activity limits (ASPS on cryolipolysis). After Avéli, 73.5% of study patients were back to normal activities inside a week (FDA clearance K221336)
When results showCryolipolysis: treated fat cells are cleared over 4 to 6 months (ASPS on cryolipolysis). Avéli: benefit shown out to one year (FDA clearance K221336)

Fat Devices

Reducing fat without surgery

Non-invasive fat devices use one of three approaches: cold, heat, or heat paired with muscle stimulation. Two limits apply to all of them. First, they are not weight-loss treatments: ASPS puts the average fat reduction in a cryolipolysis-treated area at about 20 percent (ASPS on cryolipolysis) and says no non-surgical option replaces liposuction (ASPS on nonsurgical fat reduction). Second, the body-area clearances for CoolSculpting (FDA clearance K233732) and SculpSure (FDA clearance K182741) apply only up to a BMI of 30.

Cold: CoolSculpting Elite

CoolSculpting Elite cools the skin over the fat toward a target temperature of as low as -11 °C (FDA clearance K233732), and the body removes the injured fat cells over the next four to six months (ASPS on cryolipolysis).

Its clearance lists cold-assisted lipolysis of the upper arm, bra fat, back fat, banana roll, thigh, flank and abdomen for people with a BMI of 30 or lower. For the submental and submandibular areas (beneath the chin and along the jawline), the BMI ceiling rises to 46.2 (FDA clearance K233732).

ASPS describes a session of about an hour and an average fat loss of about 20 percent, and lists asymmetry and surface irregularities among the risks. It also says cryolipolysis is not for people with cold urticaria, paroxysmal cold hemoglobinuria or cryoglobulinemia (ASPS on cryolipolysis). The section below covers paradoxical adipose hyperplasia, the complication most worth asking about.

Laser: SculpSure

SculpSure uses a 1060 nm laser. It is cleared for non-invasive lipolysis of the thighs, back, flanks and abdomen at a BMI of 30 or lower, and of the submental area at a BMI of 49 or lower (FDA clearance K182741). A single-arm study treated the abdomens of 29 patients once, for 25 minutes, with a 1060 nm diode laser; at 12 weeks, ultrasound measured an 8.55% fat reduction (Kislevitz et al., 2021).

Radiofrequency: truSculpt

truSculpt heats tissue with radiofrequency energy. Its FDA file reports that the applicator held the skin surface at 40 to 45 °C. The clearance covers non-invasive lipolysis and reduction of abdominal circumference, with the 2 MHz mode and the 40 cm² handpiece (FDA clearance K223110).

Radiofrequency plus muscle stimulation: Emsculpt Neo

Emsculpt Neo adds muscle stimulation to radiofrequency heating, and its FDA file states a therapy temperature of 40 to 43 °C (FDA clearance K192224). Its evidence is covered in the muscle section further down.

PAH

Paradoxical adipose hyperplasia after cryolipolysis

With paradoxical adipose hyperplasia (PAH), a treated area gets a firm, larger fat deposit instead of a smaller one. The published rates do not agree:

SourceRate reported
The first published report (Jalian et al., 2014)0.0051%
A single practice (Singh et al., 2015)0.47%, or 2 in 422 treatments; the authors called this 100 times the rate the manufacturer reported
8 Canadian centers, 8,658 cycles (Nikolis and Enright, 2021)0.05% to 0.39%; rates dropped by more than 75% once newer device models were in use
Meta-analysis of 28 studies, 13,078 patients (Mah et al., 2025)0.22%, on evidence graded low-certainty
The manufacturer (Allergan CoolSculpting FAQ)About 1 in 3,000 treatments (0.033%)

Who is at higher risk. ASPS reports that men develop PAH three times as often as women and that it is seen more in people of Hispanic or Latino descent (ASPS on cryolipolysis). The 2025 meta-analysis did not find a statistically significant difference by sex (Mah et al., 2025).

What happens if it occurs. The 2014 authors saw nothing to suggest PAH goes away by itself (Jalian et al., 2014). A 2018 case series followed 11 patients. Seven of them had surgery: six had liposuction and one had liposuction combined with abdominoplasty. The surgeons waited until the tissue softened, typically 6 to 9 months after the cryolipolysis, and three of the liposuction patients later needed a second procedure (Kelly et al., 2018).

Have the provider walk you through PAH before you consent to CoolSculpting.

Chin

Kybella for fat under the chin

Kybella (deoxycholic acid) is FDA-approved to improve the look of moderate to severe fullness from submental fat in adults. One session can involve as many as 50 small injections, and a patient may have as many as 6 sessions, each at least 1 month after the last. The two placebo-controlled trials gave Kybella to 513 patients and placebo to 506 (Kybella label).

The approval covers the chin area and nothing else. The label says use on fat outside the submental region is neither approved nor recommended, and lists serious reactions reported after such use: muscle or nerve injury and, when injected close to the eyes, blurred or reduced vision (Kybella label). A provider who proposes Kybella for another body area should explain why.

What the trials and label record:

  • Uneven smile. Marginal mandibular nerve injury occurred in 4% of Kybella patients. Every case cleared up without treatment, after anywhere from 1 to 298 days, with a median of 44 days.
  • Swallowing. Trouble swallowing occurred in 2% of patients.
  • Numbness. Swelling, bruising, pain and numbness are common, and 42% of patients had numbness lasting over 30 days.
  • Injection-site problems. The label also lists ulceration, necrosis, nodules, masses and infection where the drug was injected (Kybella label).

This site lists no Dallas price range for Kybella or for any of the fat devices above.

Muscle

Muscle: Emsculpt Neo and HIFEM

What the clearance covers. Emsculpt Neo is cleared for non-invasive lipolysis and a reduced abdominal circumference (FDA clearance K192224).

The clearance study. Forty-two people with a BMI of 35 or lower were enrolled. At three months, mean abdominal circumference was down 3.2 cm and ultrasound showed mean fat down 29.8%. The study had one arm and no controls (FDA clearance K192224). The BMI cap of 35 was only an enrollment rule; it is not written into the cleared indication.

The original Emsculpt. This earlier device stimulates muscle with no radiofrequency. An MRI study measured 22 patients two months after four sessions and found fat thickness down 18.6%, rectus abdominis thickness up 15.4% and abdominal muscle separation reduced by 10.4% (Kinney and Lozanova, 2019).

The wider evidence. A 2023 systematic review collected 15 clinical studies of Emsculpt and Emsculpt Neo; only two covered Emsculpt Neo. Pooled abdominal results showed mean fat thickness down 5.5 mm, muscle thickness up 2 mm and muscle separation improved by 3.0 mm. Two of the studies found marginal or no benefit, and no study recorded any change in weight (Kohan et al., 2023).

Skin

Tightening skin, and where devices stop

Energy devices tighten skin by heating it so the tissue contracts. Removing skin is different; it takes an operation, a tummy tuck being one example (ASPS on tummy tuck).

Morpheus8 (fractional RF microneedling)

An array of pins carries radiofrequency energy into the skin. The clearance covers dermatologic procedures needing hemostasis or the coagulation or contraction of soft tissue (FDA clearance K231790). An FDA safety communication about RF microneedling, dated October 15, 2025, says the agency is aware of reported nerve damage, disfigurement, fat loss, scarring and burns, some of which needed medical care or surgical repair (FDA on RF microneedling).

BodyTite (RF-assisted liposuction)

A search of the FDA 510(k) database under the name BodyTite returns no entry. Ask the provider for the 510(k) number that covers the device and what that clearance allows.

Renuvion / J-Plasma (helium plasma and RF)

The FDA warned in March 2022 against using Renuvion/J-Plasma for skin contraction and dermal resurfacing; at that point it had not been found safe or effective for any aesthetic skin procedure. After narrower clearances, the FDA updated the communication on May 10, 2023 (FDA on Renuvion/J-Plasma). Two handpieces now have clearances:

  • Renuvion Dermal Handpiece: moderate to severe wrinkles, for Fitzpatrick skin types I to III (FDA on Renuvion/J-Plasma).
  • Renuvion APR Handpiece: lax skin of the neck and submental region, and coagulation of subcutaneous tissue after liposuction for body contouring (FDA clearance K230272).

If your area is not on either list, ask why the provider is proposing it.

Cellulite

Cellulite

Avéli. A handheld tool goes through a small incision and cuts the fibrous bands (septa) that tether cellulite dimples (FDA clearance K221336). The FDA cleared it for long-term reduction in the appearance of cellulite on adult women’s buttocks and thighs, with data supporting benefit out to one year. Seventy-four women had one treatment each in the pivotal study. It reached its primary endpoint, a mean gain of more than 1 point on the Cellulite Severity Scale at 3 months, and the improvement held at 6 and 12 months. Bruising was the most frequent side effect (86.8%), followed by tenderness (51.5%), pain (38.2%), firmness (36.8%) and numbness (17.6%) (FDA clearance K221336).

truSculpt massage device. Cleared for a temporary reduction in the appearance of cellulite (FDA clearance K223110).

Qwo. On December 6, 2022, Endo said it would end production and sales of this injectable cellulite drug, pointing to concerns about bruising and the possibility of long-lasting skin discoloration (Endo SEC filing).

Liposuction. ASPS says it is not an effective cellulite treatment (ASPS on liposuction).

GLP-1

After GLP-1 weight loss

Losing weight on a GLP-1 drug removes lean mass as well as fat. In a SURMOUNT-1 substudy, 160 participants were followed for 72 weeks. On tirzepatide they lost 21.3% of body weight, 33.9% of fat mass and 10.9% of lean mass, so lean mass was about 25% of the total loss, the same share as on placebo (Look et al., 2025).

Once the weight is off, what to do depends mostly on the skin that remains:

  • Cryolipolysis may be a poor fit when tone is poor or skin is loose (ASPS on cryolipolysis).
  • Energy devices such as Morpheus8 can coagulate or contract soft tissue under their clearance (FDA clearance K231790), but they do not take skin away.
  • Liposuction reshapes skin less well when weight loss has left it thin and soft, according to ASPS, and further surgery to remove the excess may follow (ASPS on liposuction).
  • A tummy tuck removes surplus skin and fat; ASPS advises waiting if more substantial weight loss is planned (ASPS on tummy tuck).

If you are on a GLP-1 drug, tell the provider before any procedure and ask whether it changes the plan.

Surgery

Surgical options

Your consultation exam answers this, and three things count most: skin laxity, muscle separation and body weight.

  • Liposuction surgically removes surplus fat from chosen areas. ASPS says good candidates are at a normal weight with some extra fat, and that results are better when skin is firm and elastic. It is not a treatment for obesity and does not stand in for diet and exercise (ASPS on liposuction).
  • Abdominoplasty (tummy tuck) removes surplus skin and fat and usually repairs separated or weakened abdominal muscles. Stretch marks remain, and it is no substitute for weight loss. ASPS advises postponing it ahead of a planned pregnancy or substantial weight loss (ASPS on tummy tuck).
  • Non-surgical fat reduction works on one fat bulge at a time, and ASPS says none of these methods replaces liposuction (ASPS on nonsurgical fat reduction).

If you are weighing surgery, ask the surgeon about board certification and look up their Texas license on the Texas Medical Board’s Look Up a License page.

What to Expect

The visit, the treatment and the weeks after

At the consultation. Expect questions about GLP-1 drugs, pregnancy and breastfeeding, cold-related conditions (for cryolipolysis), and swallowing or bleeding problems (for Kybella) (ASPS on cryolipolysis) (Kybella label). The provider should also establish whether your concern is fat, muscle, loose skin or cellulite.

After treatment. The timeline uses the published figures for each treatment. Your own plan and follow-up dates come from your provider.

  1. Treatment day

    Avéli is a single treatment through a small incision (FDA clearance K221336). Kybella involves as many as 50 small injections under the chin (Kybella label). A cryolipolysis treatment takes about an hour, and ASPS lists no activity restrictions after it (ASPS on cryolipolysis).

  2. The first few weeks

    After Avéli, 73.5% of study patients were doing normal activities inside a week, and bruising lasted a median of 27 days (FDA clearance K221336). Kybella commonly brings swelling, bruising, pain and numbness (Kybella label). Cryolipolysis can leave a soreness some people compare to the day after a workout (ASPS on cryolipolysis).

  3. Months 1 to 3

    The Avéli study took its primary measurement at 3 months (FDA clearance K221336). The Emsculpt Neo clearance study measured patients 1, 2 and 3 months after their last session (FDA clearance K192224). Further Kybella sessions come at least 1 month apart (Kybella label).

  4. Months 4 to 6

    Treated fat cells from cryolipolysis are cleared over this four to six month window (ASPS on cryolipolysis). An area that becomes larger and firmer instead of shrinking should be checked for paradoxical adipose hyperplasia (Jalian et al., 2014).

  5. 12 months

    Avéli's pivotal study showed the result lasting out to one year (FDA clearance K221336).

Cost

What it costs in Dallas

This site does not publish a Dallas price range for body contouring. The total depends on the device, the number of areas and the number of sessions. Get the full figure in writing, and have it spell out required packages, follow-up visits, and the policy for touch-ups and complications.

Combinations

Pairing treatments

Fat, muscle and skin respond to different methods, so plans often combine them. For each item in a combined plan, ask what it is for, where it falls in the sequence, and what its FDA clearance covers. Related pages: RF microneedling, dermal fillers, and wellness and HRT.

Texas Law

Choosing a provider around Dallas

The Texas rules. Delegated non-surgical medical cosmetic procedures are governed by 22 TAC Chapter 169, Subchapter E, as amended by Texas Medical Board rule changes in effect from January 9, 2025 (Texas Medical Board). What they require:

  • A relationship first. Before a delegated procedure, a physician must establish a practitioner-patient relationship with you, or a PA or APRN may do it under the physician’s delegation. Clinics often call this the good faith exam (22 TAC §169.26).
  • Someone available. During the procedure, a physician, PA or APRN has to be on site or immediately available for emergency consultation if something goes wrong (22 TAC §169.26).
  • Paperwork. Delegation needs a written order naming the delegating physician and covering patient screening criteria, a description of appropriate care, and how complications and emergencies are handled (22 TAC §169.27). The person performing the procedure signs and dates a written protocol (22 TAC §169.26).
  • A posted license. The delegating physician’s name and Texas license number must be on display in every public area and treatment room (22 TAC §169.28).

What to ask:

  • Which physician delegates, and which person will actually treat me?
  • Is the device an authentic, current model from the manufacturer? One multicenter study saw PAH rates fall by over 75% after newer CoolSculpting models arrived (Nikolis and Enright, 2021).
  • Does the device’s FDA clearance cover my area?
  • For CoolSculpting: what do you tell patients about PAH, and what is your plan if it happens?
  • What reduction should I expect, and how will you measure it? ASPS gives about 20 percent on average for cryolipolysis (ASPS on cryolipolysis).
  • What is the full price, and how do you handle complications and revisions?

Looking up a license:

Areas

Body areas and their cleared devices

Treatment Areas

Areas treated

Flanks and stomach Inner and outer thighs Upper arms Bra line and back Buttocks Banana roll, the fold below the buttocks Submental area (under the chin) Dimpled cellulite on buttocks and thighs Skin left loose by pregnancy Skin left over after weight loss

Frequently asked questions

Can body contouring help me lose weight?

It is not built for that. Each of these treatments works on one area of fat and leaves total body weight largely unchanged. ASPS gives an average of roughly 20 percent fat reduction in an area treated with cryolipolysis (ASPS on cryolipolysis) and says no non-surgical method takes the place of liposuction (ASPS on nonsurgical fat reduction). The body-area clearances for CoolSculpting (FDA clearance K233732) and SculpSure (FDA clearance K182741) stop at a BMI of 30. An operation is not a weight-loss tool either: ASPS states that a tummy tuck does not substitute for losing weight, and that people expecting major weight loss should hold off (ASPS on tummy tuck).

What separates a fat reduction device from a skin tightening device?

A fat reduction device damages fat cells in the treated spot. Four have FDA clearance for non-invasive lipolysis: CoolSculpting, which uses cold (FDA clearance K233732); SculpSure, which uses a laser (FDA clearance K182741); truSculpt iD, which uses radiofrequency on the abdomen (FDA clearance K223110); and Emsculpt Neo, also cleared for the abdomen (FDA clearance K192224). A skin tightening device heats tissue so that it contracts. Morpheus8's clearance is for dermatologic procedures needing soft tissue coagulation or contraction (FDA clearance K231790), and Renuvion's covers lax neck and submental skin plus use after liposuction (FDA clearance K230272). Removing a lot of loose skin takes an operation such as a tummy tuck, which cuts away surplus skin and fat (ASPS on tummy tuck).

How often does CoolSculpting cause paradoxical adipose hyperplasia (PAH), and who is more likely to get it?

In PAH, the treated area grows a firm, larger patch of fat instead of shrinking. It is rare, but estimates differ widely. The first published figure was 0.0051% (Jalian et al., 2014). Pooling 28 studies, a 2025 meta-analysis found 29 cases among 13,078 patients, which is 0.22% or roughly 1 in 455, and graded the evidence as low-certainty (Mah et al., 2025). The maker, Allergan, cites about 1 in 3,000 treatments, or 0.033% (Allergan CoolSculpting FAQ). ASPS says PAH affects under 1 percent of patients, is three times as likely in men as in women and occurs more often in people of Hispanic or Latino descent (ASPS on cryolipolysis). A 2018 case series found that PAH did not go away untreated; patients had liposuction, a few with abdominoplasty added, and some needed another operation (Kelly et al., 2018). Ask your provider to cover PAH with you before you sign a consent form.

I lost weight on a GLP-1 drug. Which contouring options fit?

Start with how much loose skin is left. ASPS notes that poor tone or loose skin can make a person a poor cryolipolysis candidate (ASPS on cryolipolysis). Morpheus8 and similar energy devices have clearance to coagulate or contract soft tissue (FDA clearance K231790), but none of them takes skin away. A tummy tuck cuts out surplus skin and fat and usually repairs separated or weakened abdominal muscles too (ASPS on tummy tuck). Some GLP-1 weight loss is muscle. In a body composition substudy of SURMOUNT-1, roughly 25% of the weight people lost on tirzepatide was lean mass, matching the placebo group (Look et al., 2025). ASPS recommends putting off a tummy tuck if a lot more weight loss is still ahead (ASPS on tummy tuck).

How do I know whether I need surgery instead?

The consultation exam settles it, and the two biggest factors are loose skin and separated muscle. ASPS says poor tone or loose skin can disqualify someone as a good candidate for cryolipolysis (ASPS on cryolipolysis). Abdominoplasty takes out surplus skin and fat and in most cases fixes weakened or separated abdominal muscles. Stretch marks stay. ASPS advises waiting on it if you plan a pregnancy or a large weight loss (ASPS on tummy tuck).

How many sessions will I need, and how long until I see a change?

Your provider builds the plan, and it varies by device and area. CoolSculpting: ASPS says treated fat cells are cleared over four to six months, and some people return to retreat an area (ASPS on cryolipolysis). Emsculpt and Emsculpt Neo: most published protocols used four sessions over two to four weeks, and the full range ran from three to eight (Kohan et al., 2023). Avéli: the pivotal study gave one treatment and showed benefit out to one year (FDA clearance K221336). For other devices, ask for the expected number of sessions and the date your result will be measured.

How good is the evidence behind Emsculpt Neo?

Thin. Of 15 clinical studies on Emsculpt and Emsculpt Neo pulled together in a 2023 systematic review, only two were on Emsculpt Neo. On average, abdominal fat thickness fell by 5.5 mm and muscle thickness rose by 2 mm. Two studies found little or no benefit, and not one reported a change in weight (Kohan et al., 2023). The FDA clearance study, run by the manufacturer on 42 people, reported a mean 3.2 cm drop in abdominal circumference and a mean 29.8% ultrasound-measured fat reduction at three months. It had a single arm with no control group (FDA clearance K192224). Ask what change is realistic for your area and how it will be measured.

Is it safe to combine treatments?

Combinations are common because fat, muscle and skin each respond to a different method. Ask the provider to justify each item in the plan, to give the order and the gap between treatments, and to say what each one is cleared for. CoolSculpting, for example, is cleared for submental fat in addition to its listed body areas (FDA clearance K233732). Kybella is limited to fullness from submental fat (Kybella label). Avéli's clearance is for cellulite on the buttocks and thighs of adult women (FDA clearance K221336).

Can I have body contouring while pregnant or breastfeeding?

No. ASPS says non-surgical fat reduction is not for anyone pregnant or breastfeeding (ASPS on nonsurgical fat reduction). Kybella's label states that the drug has not been adequately studied in pregnancy and that there is no information on whether it reaches breast milk (Kybella label). For women who may become pregnant later, ASPS advises postponing a tummy tuck (ASPS on tummy tuck). Ask your provider how long to wait after you finish breastfeeding.

What should I ask a Dallas provider before I book?

First, find out who the delegating physician is. Texas rules require that physician's name and Texas license number to be posted in each public area and each treatment room (22 TAC §169.28). Then work through this list: (1) Which physician delegates the procedure? (2) If it is CoolSculpting, how do you explain the risk of paradoxical adipose hyperplasia, and what is the plan if I develop it? (3) Is the machine an authentic, current model from its manufacturer? (4) Who will treat me, and what training do they have? (5) Is my area inside the device's FDA clearance? Renuvion's, for example, covers lax skin of the neck and submental area (FDA clearance K230272). (6) What is the full price, including any required package? (7) How do you handle complications and revisions?

Body Contouring by Dallas neighborhood

Medical disclaimer. This page is for education and is not medical advice. It covers devices that work from outside the body, minimally invasive procedures and surgery, and each carries its own risks. Published rates of paradoxical adipose hyperplasia (PAH) after cryolipolysis range from 0.0051% (Jalian, 2014) to 0.47% at one practice (Singh, 2015); a 2025 meta-analysis pooled them at 0.22%. In March 2022 the FDA warned against Renuvion/J-Plasma for dermal resurfacing and skin contraction, and it revised that warning on May 10, 2023. No non-invasive device removes loose skin. Check the delegating physician's Texas license before you are treated. Med Spas of Dallas is a directory. It does not treat patients, endorse any treatment or promise any result.

References
  1. [1] U.S. Food and Drug Administration. 510(k) K233732: CoolSculpting Elite System (ZELTIQ Aesthetics), September 12, 2024. Body areas for BMI 30 or less; submental and submandibular areas up to BMI 46.2; target temperature down to -11 °C.
  2. [2] U.S. Food and Drug Administration. 510(k) K182741: SculpSure (Cynosure), January 3, 2019. Abdomen, flanks, back and thighs for BMI 30 or less; submental area for BMI 49 or less; 1060 nm.
  3. [3] U.S. Food and Drug Administration. 510(k) K223110: truSculpt (Cutera), November 3, 2022. Abdominal lipolysis and circumference reduction; temporary reduction in the appearance of cellulite (massage device).
  4. [4] U.S. Food and Drug Administration. 510(k) K192224: BTL-899 (Emsculpt Neo, BTL Industries), December 5, 2019. Abdominal lipolysis and circumference reduction; single-arm study of 42 patients.
  5. [5] U.S. Food and Drug Administration. 510(k) K231790: InMode System with Morpheus8 Applicators, July 20, 2023.
  6. [6] U.S. Food and Drug Administration. 510(k) K230272: Renuvion APR Handpiece (Apyx Medical), 2023.
  7. [7] U.S. Food and Drug Administration. 510(k) K221336: Avéli (Revelle Aesthetics), August 5, 2022. Indication extended to benefits through one year.
  8. [8] KYBELLA (deoxycholic acid) injection prescribing information. Allergan/AbbVie. Revised 09/2026.
  9. [9] U.S. Food and Drug Administration. UPDATE: Use of Renuvion/J-Plasma Device for Certain Aesthetic Procedures: FDA Safety Communication. May 10, 2023.
  10. [10] U.S. Food and Drug Administration. Potential Risks with Certain Uses of Radiofrequency (RF) Microneedling: FDA Safety Communication. October 15, 2025.
  11. [11] Endo International plc. Endo to Cease Production and Sale of Qwo (collagenase clostridium histolyticum-aaes). Press release filed with the SEC (Form 8-K, Exhibit 99.1), December 6, 2022.
  12. [12] Jalian HR, Avram MM, Garibyan L, Mihm MC, Anderson RR. Paradoxical adipose hyperplasia after cryolipolysis. JAMA Dermatol. 2014;150(3):317 to 319. Incidence 0.0051%.
  13. [13] Singh SM, Geddes ER, Boutrous SG, Galiano RD, Friedman PM. Paradoxical adipose hyperplasia secondary to cryolipolysis: an underreported entity? Lasers Surg Med. 2015;47(6):476 to 478. Practice incidence 0.47% (2 in 422 treatments).
  14. [14] Nikolis A, Enright KM. A Multicenter Evaluation of Paradoxical Adipose Hyperplasia Following Cryolipolysis for Fat Reduction and Body Contouring: A Review of 8658 Cycles in 2114 Patients. Aesthet Surg J. 2021;41(8):932 to 941. Incidence 0.05% to 0.39%.
  15. [15] Mah AE, Razeghi P, Li C, et al. Incidence of Paradoxical Adipose Hyperplasia After Cryolipolysis: A Systematic Review and Meta-Analysis. Aesthet Surg J Open Forum. 2025;7:ojaf142. Pooled incidence 0.22%.
  16. [16] Kelly ME, Rodríguez-Feliz J, Torres C, Kelly E. Treatment of Paradoxical Adipose Hyperplasia following Cryolipolysis: A Single-Center Experience. Plast Reconstr Surg. 2018;142(1):17e to 22e.
  17. [17] Kislevitz M, Wamsley C, Kang A, et al. Clinical Evaluation of the Safety and Efficacy of a 1060-nm Diode Laser for Non-Invasive Fat Reduction of the Abdomen. Aesthet Surg J. 2021;41(10):1155 to 1165. 8.55% ultrasound-measured reduction at 12 weeks.
  18. [18] Kinney BM, Lozanova P. High intensity focused electromagnetic therapy evaluated by magnetic resonance imaging: Safety and efficacy study of a dual tissue effect based non-invasive abdominal body shaping. Lasers Surg Med. 2019;51(1):40 to 46.
  19. [19] Kohan J, Vyas K, Erotocritou M, Khajuria A, Tehrani K. High-Intensity Focused Electromagnetic (HIFEM) Energy With and Without Radiofrequency for Noninvasive Body Contouring: A Systematic Review. Aesthetic Plast Surg. 2024;48(6):1156 to 1165 (epub 2023).
  20. [20] Look M, Dunn JP, Kushner RF, et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes Obes Metab. 2025;27(5):2720 to 2729. n=160; lean mass -10.9%; about 25% of weight lost was lean mass with tirzepatide and with placebo.
  21. [21] American Society of Plastic Surgeons. Cryolipolysis.
  22. [22] American Society of Plastic Surgeons. Nonsurgical Fat Reduction.
  23. [23] American Society of Plastic Surgeons. Tummy Tuck.
  24. [24] American Society of Plastic Surgeons. Liposuction.
  25. [25] 22 Texas Administrative Code §169.26: practitioner-patient relationship before a delegated procedure; physician, PA or APRN onsite or immediately available.
  26. [26] 22 Texas Administrative Code §169.27: written order for delegated procedures.
  27. [27] 22 Texas Administrative Code §169.28: posting of the delegating physician's name and Texas license number.
  28. [28] Texas Medical Board. Rule changes effective January 9, 2025.
  29. [29] Allergan Aesthetics. CoolSculpting FAQ. Paradoxical adipose hyperplasia about 1 in 3,000 treatments (0.033%).

Find a med spa near you

Pick a neighborhood to see each med spa's Google rating, hours and phone number. Free to search, no sign-up.

Browse by neighborhood

Own a med spa? List your spa or claim your listing